LAS VEGAS, Jan. 26, 2016 /PRNewswire/ -- DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), has just signed a one-year agreement with another Nevada medicinal cannabis grower, Waveseer of Las Vegas. DigiPath Labs will use its state-of-the-art testing equipment and reliable testing methodologies to determine safety and potency profiles of Waveseer's cannabis material.
"We are excited to perform cannabis testing for Waveseer," says Todd Denkin, CEO of DigiPath, Inc. "They're dedicated to ensuring every plant meets the strict standards of the State of Nevada, and we anticipate a long, productive partnership."
"We were immediately impressed with the customer service, professionalism, testing protocol, and mission of DigiPath Labs," says Gareth Nelson, Operations Director at Waveseer of Las Vegas. "Providing safe, clean medicine to Nevada patients is our mission, and this partnership will help us in gaining patient trust and loyalty."
DigiPath Labs' state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. The team carefully selected equipment and then created and verified standard operating procedures to ensure reliable, replicable results.
Waveseer of Las Vegas is a licensed medical cannabis grower located in North Las Vegas that has been fully licensed and growing for a few months.
DigiPath Labs will test all cannabis products grown and produced by Waveseer for potency, terpenoids, moisture content, foreign matter, heavy metals, microbials, mycotoxins, and pesticide residue.
"Nevada's cannabis industry is just getting started, but it's already leading the country in terms of careful oversight and concern for patient safety," says Denkin. "Waveseer of Las Vegas is set up for success in this environment, and we look forward to helping them help patients."
To learn more about DigiPath Labs, visit www.digipathlabs.com.
About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath's two business units are DigiPath Labs and TNM News Corp.
For more information, go to www.digipath.com.
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, governmental regulation of the cannabis industry, the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
SOURCE DigiPath, Inc.